Article

Grant addresses pediatric cataracts

Bausch + Lomb (B+L) and the Lions Clubs International Foundation have given $150,000 to Tianjin Eye Hospital in China to finance a specialized pediatric cataract training initiative that will include training and education, equipment, and screenings.

Rochester, NY-Bausch + Lomb (B+L) and the Lions Clubs International Foundation have given $150,000 to Tianjin Eye Hospital in China to finance a specialized pediatric cataract training initiative that will include training and education, equipment, and screenings.

“Today, there may be as many as 40,000 children in China suffering from pediatric cataract, a condition that is treatable, and in some cases, preventable,” said Joe Barr, OD, MS, FAAO, vice president of global clinical and medical affairs and professional services, vision care, B+L. “We hope that this grant will enable Tianjin Eye Hospital to provide much-needed training and treatment in the region, so that together we can improve patient health, outcomes, and quality of life.”

The grant will be used to train the region’s ophthalmologists on the treatment and follow-up care of pediatric cataract and also to purchase portable retinoscopes and slit lamps for use in training programs and by pediatric cataract surgeons. The monies also will fund continuing education for Tianjin’s pediatric cataract surgeons.

Additionally, the grant will provide for the education of the region’s parents and healthcare workers about pediatric eye diseases, and physicians and residents at the hospital will train staff at Tianjin Maternal and Child Health Care Centers to screen for pediatric cataract.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.